Literature DB >> 18343899

Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors.

Xian-Chao Cheng1, Hao Fang, Wen-Fang Xu.   

Abstract

Matrix metalloproteinases (MMPs) play an important role in many physiological and pathological processes. To assay the activities of MMPs is important in diagnosis and therapy of the MMPs associated diseases, such as neoplastic, rheumatic and cardiovascular diseases. Several assay systems have been developed, which include bioassay, zymography assay, immunoassay, fluorimetric assay, radio isotopic assay, phage-displayed assay, multiple-enzyme/multiple-reagent assay and activity-based profiling assay. The principle, application, advantage and disadvantage of these assays have been reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343899     DOI: 10.1080/14756360701511292

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  9 in total

Review 1.  Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

Authors:  György Dormán; Sándor Cseh; István Hajdú; László Barna; Dénes Kónya; Krisztina Kupai; László Kovács; Péter Ferdinandy
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

2.  A profiling platform for the identification of selective metalloprotease inhibitors.

Authors:  Christophe Antczak; Constantin Radu; Hakim Djaballah
Journal:  J Biomol Screen       Date:  2008-03-18

3.  Profiling of Multiple Matrix Metalloproteinases Activities in the Progression of Osteosarcoma by Peptide Microarray-Based Fluorescence Assay on Polymer Brush-Coated Zinc Oxide Nanorod Substrate.

Authors:  Zhenxin Wang; Minghong Jian; Xiaotong Li
Journal:  Methods Mol Biol       Date:  2023

4.  Fine-structural distribution of MMP-2 and MMP-9 activities in the rat skeletal muscle upon training: a study by high-resolution in situ zymography.

Authors:  Marine Yeghiazaryan; Katarzyna Żybura-Broda; Anna Cabaj; Jakub Włodarczyk; Urszula Sławińska; Marcin Rylski; Grzegorz M Wilczyński
Journal:  Histochem Cell Biol       Date:  2012-03-15       Impact factor: 4.304

5.  Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3.

Authors:  Xiaoyun Tang; Todd P W McMullen; David N Brindley
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

Review 6.  Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216.

Authors:  Kristina R Gopcevic; Eugenia Gkaliagkousi; János Nemcsik; Ömür Acet; M Rosa Bernal-Lopez; Rosa M Bruno; Rachel E Climie; Nikolaos Fountoulakis; Emil Fraenkel; Antonios Lazaridis; Petras Navickas; Keith D Rochfort; Agnė Šatrauskienė; Jūratė Zupkauskienė; Dimitrios Terentes-Printzios
Journal:  Front Physiol       Date:  2021-12-14       Impact factor: 4.566

7.  Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment.

Authors:  Aditya N Bade; JoEllyn M McMillan; Yutong Liu; Benson J Edagwa; Howard E Gendelman
Journal:  Mol Neurobiol       Date:  2021-08-14       Impact factor: 5.590

Review 8.  Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights.

Authors:  Valeria Bisogni; Alberto Cerasari; Giacomo Pucci; Gaetano Vaudo
Journal:  Integr Blood Press Control       Date:  2020-11-02

Review 9.  In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach.

Authors:  Andrés Tabernilla; Bruna Dos Santos Rodrigues; Alanah Pieters; Anne Caufriez; Kaat Leroy; Raf Van Campenhout; Axelle Cooreman; Ana Rita Gomes; Emma Arnesdotter; Eva Gijbels; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.